Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 27 May 2009, doi:10.1136/bmj.b1870
Cite this as: BMJ 2009;338:b1870
Melanie Calvert, senior lecturer1, Aparna Shankar, research fellow2, Richard J McManus, clinical senior lecturer1, Helen Lester, professor of primary care3, Nick Freemantle, professor of clinical epidemiology and biostatistics1
1 Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT, 2 Department of Epidemiology and Public Health, University College London, 3 National Primary Care Research and Development Centre, University of Manchester
Correspondence to: M Calvert m.calvert{at}bham.ac.uk
Design Retrospective cohort study.
Setting 147 general practices (annual list size over 1 million) across the UK.
Patients People with type 1 or type 2 diabetes.
Main outcome measures Annual prevalence of diabetes and attainment of process and clinical outcomes over the three years before and the three years after the introduction of the quality and outcomes framework.
Results Significant improvements in process and intermediate outcome measures were observed during the six year period, with consecutive annual improvements observed before the introduction of incentives. However, the current diagnostic case definition for the quality and outcomes framework does not capture up to two thirds of people with type 1 diabetes and a third of people with type 2 diabetes. After the introduction of the quality and outcomes framework, existing trends of improvement in glycaemic control, cholesterol levels, and blood pressure were attenuated, particularly in people with diabetes who did not meet the case definition of the quality and outcomes framework. The introduction of the quality and outcomes framework did not lead to improvement in the management of patients with type 1 diabetes, nor to a reduction in the number of patients with type 2 diabetes who had HbA1c levels greater than 10%. Introduction of the quality and outcomes framework may have increased the number of patients with type 2 diabetes with HbA1c levels of
7.5%; odds ratio 1.05 (95% confidence interval 1.01 to 1.09; P=0.02).
Conclusions The management of people with diabetes has improved since the late 1990s, but the impact of the quality and outcomes framework on care is not straightforward; upper thresholds may need to be removed or targets made more challenging if people are to benefit. Many patients in whom care may be suboptimal may not be captured in the quality and outcomes framework assessment.
© Calvert et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses